{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:20:31Z","timestamp":1788877231601,"version":"build-2803163510"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008223","name":"Universidade Federal do Paran\u00e1","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008223","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.expneurol.2017.11.009","type":"journal-article","created":{"date-parts":[[2017,11,21]],"date-time":"2017-11-21T20:15:35Z","timestamp":1511295335000},"page":"188-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"special_numbering":"C","title":["Pioglitazone reduces mortality, prevents depressive-like behavior, and impacts hippocampal neurogenesis in the 6-OHDA model of Parkinson's disease in rats"],"prefix":"10.1016","volume":"300","author":[{"given":"J\u00e9ssica Mendes","family":"Bonato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taysa Bervian","family":"Bassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humberto","family":"Milani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Aparecida Barbato Fraz\u00e3o","family":"Vital","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6181-1881","authenticated-orcid":false,"given":"R\u00fabia Maria Weffort","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.expneurol.2017.11.009_bb0005","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrn.2017.45","article-title":"Adult hippocampal neurogenesis and cognitive flexibility - linking memory and mood","volume":"18","author":"Anacker","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2017.11.009_bb0010","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jns.2016.12.060","article-title":"Neuropsychiatric symptoms, behavioural disorders, and quality of life in Parkinson's disease","volume":"373","author":"Balestrino","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2017.11.009_bb0015","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.bbr.2014.08.014","article-title":"Neuroprotective effects of peroxisome proliferator-activated receptor alpha and gamma agonists in model of parkinsonism induced by intranigral 1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine","volume":"274","author":"Barbiero","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2017.11.009_bb0020","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.med.53.082901.104018","article-title":"The mechanisms of action of PPARs","volume":"53","author":"Berger","year":"2002","journal-title":"Annu Rev Med."},{"issue":"3","key":"10.1016\/j.expneurol.2017.11.009_bb0025","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/jnc.13278","article-title":"Parkinson's disease, anxious depression and serotonin-zooming in on hippocampal neurogenesis","volume":"135","author":"Blum","year":"2015","journal-title":"J Neurochem. Nov"},{"issue":"13","key":"10.1016\/j.expneurol.2017.11.009_bb0030","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1002\/mds.23230","article-title":"2010. Anxious personality predicts an increased risk of Parkinson's disease","volume":"25","author":"Bower","year":"2010","journal-title":"Mov. Disord."},{"issue":"7","key":"10.1016\/j.expneurol.2017.11.009_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001854","article-title":"Glitazone treatment and incidence of Parkinson's disease among people with diabetes: a retrospective cohort study","volume":"12","author":"Brauer","year":"2015","journal-title":"PLoS Med."},{"issue":"3","key":"10.1016\/j.expneurol.2017.11.009_bb0040","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1046\/j.1471-4159.2002.00990.x","article-title":"Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson's disease","volume":"82","author":"Breidert","year":"2002","journal-title":"J Neurochem. Aug"},{"key":"10.1016\/j.expneurol.2017.11.009_bb0045","doi-asserted-by":"crossref","first-page":"1):1","DOI":"10.1002\/cne.10874","article-title":"Transient expression of doublecortin during adult neurogenesis","volume":"467","author":"Brown","year":"2003","journal-title":"J Comp Neurol."},{"issue":"5","key":"10.1016\/j.expneurol.2017.11.009_bb0050","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1177\/0269881111424456","article-title":"Involvement of PI3K, GSK-3\u03b2 and PPAR\u03b3 in the antidepressant-like effect of folic acid in the forced swimming test in mice","volume":"26","author":"Budni","year":"2012","journal-title":"J Psychopharmacol."},{"issue":"6","key":"10.1016\/j.expneurol.2017.11.009_bb0055","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1017\/S1461145712001502","article-title":"The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system","volume":"16","author":"Campos","year":"2013","journal-title":"Int J Neuropsychopharmacol."},{"issue":"7","key":"10.1016\/j.expneurol.2017.11.009_bb0060","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2174\/1389450111314070004","article-title":"PPAR-\u03b3: therapeutic prospects in Parkinson's disease","volume":"14","author":"Carta","year":"2013","journal-title":"Curr Drug Targets"},{"issue":"2","key":"10.1016\/j.expneurol.2017.11.009_bb0065","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1517\/13543784.2015.963195","article-title":"Thiazolidinediones under preclinical and early clinical development for the treatment of Parkinson's disease","volume":"24","author":"Carta","year":"2015","journal-title":"Expert Opin Investig Drugs"},{"issue":"5","key":"10.1016\/j.expneurol.2017.11.009_bb0070","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","article-title":"Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment","volume":"8","author":"Chaudhuri","year":"2009","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.expneurol.2017.11.009_bb0075","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1046\/j.1460-9568.2002.01938.x","article-title":"Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging","volume":"15","author":"Cicchetti","year":"2002","journal-title":"Eur J Neurosci."},{"key":"10.1016\/j.expneurol.2017.11.009_bb0080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/NDT.S121149","article-title":"Pioglitazone could induce remission in major depression: a meta-analysis","volume":"13","author":"Colle","year":"2016","journal-title":"Neuropsychiatr Dis Treat."},{"issue":"16","key":"10.1016\/j.expneurol.2017.11.009_bb0085","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1523\/JNEUROSCI.0066-08.2008","article-title":"Alpha-synuclein alters Notch-1 expression and neurogenesis in mouse embryonic stem cells and in the hippocampus of transgenic mice","volume":"28","author":"Crews","year":"2008","journal-title":"J Neurosci."},{"issue":"6","key":"10.1016\/j.expneurol.2017.11.009_bb0090","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.neuropharm.2009.12.013","article-title":"Hippocampal neurogenesis as a target for the treatment of mental illness: a critical evaluation","volume":"58","author":"DeCarolis","year":"2010","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.expneurol.2017.11.009_bb0095","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1046\/j.1471-4159.2003.02210.x","article-title":"Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation","volume":"88","author":"Dehmer","year":"2004","journal-title":"J Neurochem."},{"key":"10.1016\/j.expneurol.2017.11.009_bb0100","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.neuroscience.2011.11.024","article-title":"Effects of noradrenaline and serotonin depletions on the neuronal activity of globus pallidus and substantia nigra pars reticulata in experimental parkinsonism","volume":"202","author":"Delaville","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2017.11.009_bb0105","doi-asserted-by":"crossref","first-page":"959154","DOI":"10.1155\/2014\/959154","article-title":"Hippocampal proliferation is increased in presymptomatic Parkinson's disease and due to microglia","volume":"2014","author":"Doorn","year":"2014","journal-title":"Neural Plast."},{"key":"10.1016\/j.expneurol.2017.11.009_bb0110","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neuroscience.2015.11.005","article-title":"Pioglitazone significantly prevented decreased rate of neural differentiation of mouse embryonic stem cells which was reduced by Pex11\u03b2 knock-down","volume":"312","author":"Esmaeili","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2017.11.009_bb0115","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.nbd.2015.07.010","article-title":"The combined depletion of monoamines alters the effectiveness of subthalamic deep brain stimulation","volume":"82","author":"Faggiani","year":"2015","journal-title":"Neurobiol Dis."},{"issue":"1","key":"10.1016\/j.expneurol.2017.11.009_bb0120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/13543784.2017.1265504","article-title":"Pioglitazone for the treatment of Alzheimer's disease","volume":"26","author":"Galimberti","year":"2017","journal-title":"Expert Opin Investig Drugs"},{"issue":"10","key":"10.1016\/j.expneurol.2017.11.009_bb0125","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/BF03347546","article-title":"Pleiotropic effects of thiazolidinediones: taking a look beyond antidiabetic activity","volume":"27","author":"Giannini","year":"2004","journal-title":"J Endocrinol Invest."},{"issue":"1\u20133","key":"10.1016\/j.expneurol.2017.11.009_bb0130","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.schres.2015.01.015","article-title":"Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol","volume":"164","author":"Gomes","year":"2015","journal-title":"Schizophr Res"},{"issue":"1\u20132","key":"10.1016\/j.expneurol.2017.11.009_bb0135","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00427-012-0425-5","article-title":"2013. Comparative aspects of adult neural stem cell activity in vertebrates","volume":"223","author":"Grandel","year":"2013","journal-title":"Dev. Genes Evol."},{"issue":"7","key":"10.1016\/j.expneurol.2017.11.009_bb0140","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nn1265","article-title":"Dopamine depletion impairs precursor cell proliferation in Parkinson disease","volume":"7","author":"H\u00f6glinger","year":"2004","journal-title":"Nat Neurosci."},{"issue":"5","key":"10.1016\/j.expneurol.2017.11.009_bb0145","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/j.1471-4159.2006.04327.x","article-title":"Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system","volume":"100","author":"Hunter","year":"2007","journal-title":"J Neurochem."},{"issue":"2","key":"10.1016\/j.expneurol.2017.11.009_bb0150","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/hup.2517","article-title":"The effects of pioglitazone adjuvant therapy on negative symptoms of patients with chronic schizophrenia: a double-blind and placebo-controlled trial","volume":"31","author":"Iranpour","year":"2016","journal-title":"Hum Psychopharmacol."},{"issue":"2","key":"10.1016\/j.expneurol.2017.11.009_bb0155","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.expneurol.2008.12.007","article-title":"Acute neuroprotection by pioglitazone after mild brain ischemia without effect on long-term outcome","volume":"216","author":"Ji","year":"2009","journal-title":"Exp Neurol."},{"issue":"1-2","key":"10.1016\/j.expneurol.2017.11.009_bb0160","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jneuroim.2009.04.011","article-title":"A pilot test of pioglitazone as an add-on in patients with relapsing remitting multiple sclerosis","volume":"211","author":"Kaiser","year":"2009","journal-title":"J Neuroimmunol."},{"issue":"13","key":"10.1016\/j.expneurol.2017.11.009_bb0165","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.2741\/2802","article-title":"Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists","volume":"1","author":"Kapadia","year":"2008","journal-title":"Front Biosci."},{"issue":"2","key":"10.1016\/j.expneurol.2017.11.009_bb0170","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2337\/diab.43.2.204","article-title":"Pioglitazone increases insulin sensitivity, reduces blood glucose, insulin, and lipid levels, and lowers blood pressure, in obese, insulin-resistant rhesus monkeys","volume":"43","author":"Kemnitz","year":"1994","journal-title":"Diabetes"},{"issue":"14","key":"10.1016\/j.expneurol.2017.11.009_bb0175","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1056\/NEJMoa1506930","article-title":"IRIS Trial Investigators. Pioglitazone after ischemic stroke or transient ischemic attack","volume":"374","author":"Kernan","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.expneurol.2017.11.009_bb0180","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.biopsych.2006.04.009","article-title":"Juvenile administration of methylphenidate attenuates adult hippocampal neurogenesis","volume":"60","author":"Lagace","year":"2006","journal-title":"Biol Psychiatry"},{"issue":"5","key":"10.1016\/j.expneurol.2017.11.009_bb0185","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.phrs.2012.02.008","article-title":"Differential susceptibility to the PPAR-\u03b3 agonist pioglitazone in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 6-hydroxydopamine rodent models of Parkinson's disease","volume":"65","author":"Laloux","year":"2012","journal-title":"Pharmacol Res."},{"key":"10.1016\/j.expneurol.2017.11.009_bb0190","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.neuroscience.2016.10.001","article-title":"Absence of neurogenic response following robust predatorinduced stress response","volume":"339","author":"Lau","year":"2016","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.expneurol.2017.11.009_bb0195","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.neubiorev.2006.03.006","article-title":"Habituation in rodents: a review of behavior, neurobiology, and genetics","volume":"30","author":"Leussis","year":"2006","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"4","key":"10.1016\/j.expneurol.2017.11.009_bb0200","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2174\/187152712800792893","article-title":"Motor and non-motor features of Parkinson's disease - a review of clinical and experimental studies","volume":"11","author":"Lima","year":"2012","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"2","key":"10.1016\/j.expneurol.2017.11.009_bb0205","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.bbr.2004.09.004","article-title":"Structure of the rat behaviour in the forced swimming test","volume":"158","author":"Lino-de-Oliveira","year":"2005","journal-title":"Behav Brain Res."},{"issue":"9","key":"10.1016\/j.expneurol.2017.11.009_bb0210","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/sj.npp.1300234","article-title":"Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment","volume":"28","author":"Malberg","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.expneurol.2017.11.009_bb0215","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13024-017-0158-z","article-title":"Defining the contribution of neuroinflammation to Parkinson's disease in humanized immune system mice","volume":"12","author":"Manocha","year":"2017","journal-title":"Mol Neurodegener."},{"issue":"3","key":"10.1016\/j.expneurol.2017.11.009_bb0220","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00018-012-1062-x","article-title":"Adult neurogenesis in Parkinson's disease","volume":"70","author":"Marxreiter","year":"2013","journal-title":"Cell Mol Life Sci."},{"key":"10.1016\/j.expneurol.2017.11.009_bb0230","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.neuro.28.051804.101459","article-title":"Adult neurogenesis in the mammalian central nervous system","volume":"28","author":"Ming","year":"2005","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2017.11.009_bb0235","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pnpbp.2016.11.005","article-title":"Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia","volume":"75","author":"Mori","year":"2017","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.expneurol.2017.11.009_bb0240","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2047-9158-3-5","article-title":"The effects of exercise on cognition in Parkinson's disease: a systematic review","volume":"3","author":"Murray","year":"2014","journal-title":"Transl Neurodegener."},{"issue":"2","key":"10.1016\/j.expneurol.2017.11.009_bb0245","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/mds.22760","article-title":"Anxious and depressive symptoms in Parkinson's disease: the French cross-sectional DoPaMiP study","volume":"25","author":"N\u00e8gre-Pag\u00e8s","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2017.11.009_bb0255","series-title":"The Rat Brain in Sterotaxic Coordinates","year":"2007"},{"issue":"19","key":"10.1016\/j.expneurol.2017.11.009_bb0260","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1523\/JNEUROSCI.4829-08.2009","article-title":"A new role for FGF2 as an endogenous inhibitor of anxiety","volume":"29","author":"Perez","year":"2009","journal-title":"J. Neurosci."},{"issue":"25","key":"10.1016\/j.expneurol.2017.11.009_bb0265","article-title":"Pioglitazone ameliorates the phenotype of a novel Parkinson's disease mouse model by reducing neuroinflammation","volume":"11","author":"Pinto","year":"2016","journal-title":"Mol. Neurodegener."},{"issue":"77","key":"10.1016\/j.expneurol.2017.11.009_bb0270","article-title":"Variability of doublecortin-associated dendrite maturation in adult hippocampal neurogenesis is independent of the regulation of precursor cell proliferation","volume":"7","author":"Pl\u00fcmpe","year":"2006","journal-title":"BMC Neurosci."},{"issue":"5604","key":"10.1016\/j.expneurol.2017.11.009_bb0275","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.expneurol.2017.11.009_bb0280","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0014-2999(78)90414-4","article-title":"\"Behavioural despair\" in rats and mice: strain differences and the effects of imipramine","volume":"51","author":"Porsolt","year":"1978","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.expneurol.2017.11.009_bb0285","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s12640-013-9437-9","article-title":"Role of nuclear receptor on regulation of BDNF and neuroinflammation in hippocampus of \u03b2-amyloid animal model of Alzheimer's disease","volume":"25","author":"Prakash","year":"2014","journal-title":"Neurotox. Res."},{"issue":"1","key":"10.1016\/j.expneurol.2017.11.009_bb0290","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1600-079X.2010.00802.x","article-title":"Chronic treatment with melatonin stimulates dendrite maturation and complexity in adult hippocampal neurogenesis of mice","volume":"50","author":"Ramirez-Rodriguez","year":"2011","journal-title":"J Pineal Res."},{"issue":"5","key":"10.1016\/j.expneurol.2017.11.009_bb0295","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1159\/000242432","article-title":"Effect of pioglitazone on survival and renal function in a mouse model of polycystic kidney disease","volume":"30","author":"Raphael","year":"2009","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.expneurol.2017.11.009_bb0300","doi-asserted-by":"crossref","first-page":"454696","DOI":"10.1155\/2014\/454696","article-title":"Adult hippocampal neurogenesis in Parkinson's disease: impact on neuronal survival and plasticity","volume":"2014","author":"Regensburger","year":"2014","journal-title":"Neural Plast"},{"issue":"12","key":"10.1016\/j.expneurol.2017.11.009_bb0305","doi-asserted-by":"crossref","first-page":"e114216","DOI":"10.1371\/journal.pone.0114216","article-title":"Behavioral phenotyping of Parkin-deficient mice: looking for early preclinical features of Parkinson's disease","volume":"9","author":"Rial","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.expneurol.2017.11.009_bb9820","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.pnpbp.2008.05.020","article-title":"Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice","volume":"32","author":"Rosa","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.expneurol.2017.11.009_bb0310","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.bbr.2011.06.011","article-title":"Antidepressant-like effect of pioglitazone in the forced swimming test in mice: the role of PPAR-gamma receptor and nitric oxide pathway","volume":"224","author":"Sadaghiani","year":"2011","journal-title":"Behav. Brain Res."},{"issue":"6","key":"10.1016\/j.expneurol.2017.11.009_bb0315","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.pnpbp.2010.06.004","article-title":"Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine","volume":"34","author":"Santiago","year":"2010","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.expneurol.2017.11.009_bb0320","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrn.2017.62","article-title":"Non-motor features of Parkinson disease","volume":"18","author":"Schapira","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2017.11.009_bb0325","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neulet.2016.04.049","article-title":"Time course study of microglial and behavioral alterations induced by 6-hydroxydopamine in rats","volume":"622","author":"Silva","year":"2016","journal-title":"Neurosci. Lett."},{"issue":"3-4","key":"10.1016\/j.expneurol.2017.11.009_bb0330","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF03033565","article-title":"The 6-hydroxydopamine model of Parkinson's disease","volume":"11","author":"Simola","year":"2007","journal-title":"Neurotox. Res."},{"issue":"3","key":"10.1016\/j.expneurol.2017.11.009_bb0335","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1089\/15209150050194297","article-title":"Thiazolidinediones: a comparative review of approved uses","volume":"2","author":"Sood","year":"2000","journal-title":"Diabetes Technol. Ther."},{"issue":"2","key":"10.1016\/j.expneurol.2017.11.009_bb0340","doi-asserted-by":"crossref","first-page":"e9260","DOI":"10.1371\/journal.pone.0009260","article-title":"Destruction of dopaminergic neurons in the midbrain by 6-hydroxydopamine decreases hippocampal cell proliferation in rats: reversal by fluoxetine","volume":"5","author":"Suzuki","year":"2010","journal-title":"PLoS One"},{"issue":"91","key":"10.1016\/j.expneurol.2017.11.009_bb0345","article-title":"The PPAR-\u03b3 agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys","volume":"8","author":"Swanson","year":"2011","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.expneurol.2017.11.009_bb0350","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neuron.2011.10.003","article-title":"Orienting fate: spatial regulation of neurogenic divisions","volume":"72","author":"Wang","year":"2011","journal-title":"Neuron"},{"issue":"47","key":"10.1016\/j.expneurol.2017.11.009_bb0355","doi-asserted-by":"crossref","first-page":"16906","DOI":"10.1523\/JNEUROSCI.2723-12.2012","article-title":"Role of \u03b1-synuclein in adult neurogenesis and neuronal maturation in the dentate gyrus","volume":"32","author":"Winner","year":"2012","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.expneurol.2017.11.009_bb0360","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1185\/03007995.2014.941054","article-title":"A comparison of all-cause mortality with pioglitazone and insulin in type 2 diabetes: an expanded analysis from a retrospective cohort study","volume":"30","author":"Yang","year":"2014","journal-title":"Curr. Med. Res. Opin."},{"issue":"1","key":"10.1016\/j.expneurol.2017.11.009_bb0365","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12974-016-0728-y","article-title":"The antidepressant-like effects of pioglitazone in a chronic mild stress mouse model are associated with PPAR\u03b3-mediated alteration of microglial activation phenotypes","volume":"13","author":"Zhao","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"5","key":"10.1016\/j.expneurol.2017.11.009_bb0370","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/jnc.12010","article-title":"A comprehensive study on long-term injury to nigral dopaminergic neurons following intracerebroventricular injection of lipopolysaccharide in rats","volume":"123","author":"Zhou","year":"2012","journal-title":"J. Neurochem."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488617303230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488617303230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T13:59:54Z","timestamp":1575381594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488617303230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":73,"alternative-id":["S0014488617303230"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2017.11.009","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pioglitazone reduces mortality, prevents depressive-like behavior, and impacts hippocampal neurogenesis in the 6-OHDA model of Parkinson's disease in rats","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2017.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}